Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068458 · ClinicalTrials.gov registry record · Phase 2
Survival TRaining for ENhancing Total Health (STRENGTH)
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT00068458: Completed Phase 2 study, sponsored by Duke University.
NCT00068458 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 39 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00068458, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
RATIONALE: A home-based exercise and/or diet program may improve the quality of life of breast cancer patients by preventing an increase in body fat and weight and a loss of lean body tissue. PURPOSE: This randomized phase II trial is studying the effectiveness of three home-based diet and/or exercise programs in preventing weight gain and loss of muscle tissue in women who are receiving chemotherapy for stage I, stage II, or stage IIIA breast cancer.
Primary Outcome
Assess estimates of effect sizes and to ascertain potential feasibility of implementing a distance-medicine based diet-exercise program within the cooperative group setting.
Interventions
- DIETARY_SUPPLEMENT Calcium-Rich Diet
- OTHER Arm 2: Exercise + Calcium-Rich Diet
- OTHER Exercise + Fruit & Vegetable, Low Fat + Calcium Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2003-09 |
| Est. Completion | 2005-01 |
| Phase | Phase 2 |
What the finished NCT00068458 record still lists
NCT00068458 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 3 interventions - of which Calcium-Rich Diet is the first listed.
NCT00068458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00068458 about?
NCT00068458 is a clinical study titled "Survival TRaining for ENhancing Total Health (STRENGTH)". RATIONALE: A home-based exercise and/or diet program may improve the quality of life of breast cancer patients by preventing an increase in body fat and weight and a loss of lean body tissue. PURPOSE: This randomized phase II trial is studying the effectiveness of three home-based diet and/or exerc...
What is the current status of trial NCT00068458?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2003-09. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00068458?
The interventions under investigation include: Calcium-Rich Diet (DIETARY_SUPPLEMENT), Arm 2: Exercise + Calcium-Rich Diet (OTHER), Exercise + Fruit & Vegetable, Low Fat + Calcium Diet (OTHER).
Who is sponsoring clinical trial NCT00068458?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00068458's enrollment target sits among peer trials
39 1459th of 2000 higher than 534 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia